Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,628Cr
Rev Gr TTM
Revenue Growth TTM
5.11%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

GODAVARIB
VS
| Quarter | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | 34.1 | 12.4 | -5.8 | 2.0 | 34.2 | 2.8 |
| 271 | 353 | 501 | 535 | 354 | 411 | 467 | 527 | 439 | 417 |
Operating Profit Operating ProfitCr |
| -13.2 | 11.3 | 18.5 | -2.3 | -10.2 | 8.1 | 19.4 | 1.1 | -1.8 | 9.4 |
Other Income Other IncomeCr | 1 | 2 | 11 | 3 | 1 | 4 | 9 | 1 | -23 | -6 |
Interest Expense Interest ExpenseCr | 20 | 18 | 20 | 20 | 20 | 19 | 13 | 15 | 12 | 10 |
Depreciation DepreciationCr | 15 | 16 | 14 | 13 | 12 | 12 | 13 | 14 | 14 | 14 |
| -65 | 13 | 91 | -42 | -64 | 8 | 96 | -22 | -57 | 13 |
| 0 | -26 | 26 | -16 | 11 | 3 | 24 | -6 | -15 | 5 |
|
Growth YoY PAT Growth YoY% | | | | | -15.1 | -85.0 | 10.4 | 38.6 | 44.5 | 43.2 |
| -27.2 | 9.7 | 10.6 | -5.0 | -23.4 | 1.3 | 12.4 | -3.0 | -9.7 | 1.8 |
| -15.5 | 9.2 | 15.5 | -6.2 | -17.9 | 1.3 | 14.1 | -3.1 | -8.1 | 1.6 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 5.4 | 10.7 | 18.4 | -16.3 | 10.9 | 7.1 |
| 1,356 | 1,381 | 1,569 | 1,868 | 1,553 | 1,767 | 1,850 |
Operating Profit Operating ProfitCr |
| 7.1 | 10.3 | 7.8 | 7.3 | 7.9 | 5.5 | 7.7 |
Other Income Other IncomeCr | 14 | 8 | 8 | 8 | 14 | 17 | -19 |
Interest Expense Interest ExpenseCr | 69 | 72 | 60 | 73 | 76 | 72 | 51 |
Depreciation DepreciationCr | 45 | 47 | 48 | 50 | 60 | 50 | 53 |
| 3 | 46 | 32 | 32 | 12 | -2 | 30 |
| -1 | 19 | 13 | 12 | 0 | 22 | 7 |
|
| | 568.4 | -29.7 | 2.8 | -37.4 | -290.4 | 196.4 |
| 0.3 | 1.8 | 1.1 | 1.0 | 0.7 | -1.3 | 1.1 |
| 1.0 | 6.5 | 4.5 | 4.7 | 2.9 | -5.1 | 4.4 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 42 | 42 | 42 | 42 | 42 | 51 | 51 |
| 385 | 412 | 431 | 448 | 459 | 731 | 674 |
Current Liabilities Current LiabilitiesCr | 871 | 650 | 919 | 768 | 1,110 | 884 | 386 |
Non Current Liabilities Non Current LiabilitiesCr | 136 | 338 | 342 | 486 | 381 | 289 | 353 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 644 | 693 | 979 | 824 | 1,076 | 1,023 | 489 |
Non Current Assets Non Current AssetsCr | 790 | 749 | 754 | 919 | 915 | 932 | 974 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 250 | 130 | 45 | 197 | 185 | 6 |
Investing Cash Flow Investing Cash FlowCr | -23 | -7 | -48 | -214 | -44 | -69 |
Financing Cash Flow Financing Cash FlowCr | -226 | -121 | 6 | 28 | -151 | 64 |
|
Free Cash Flow Free Cash FlowCr | 223 | 119 | -5 | -20 | 130 | -65 |
| 6,142.5 | 478.5 | 234.9 | 1,003.0 | 1,505.7 | -26.3 |
CFO To EBITDA CFO To EBITDA% | 241.5 | 82.4 | 33.8 | 134.7 | 138.7 | 5.9 |
| Financial Year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 0 | 751 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 |
| 5.1 | 3.4 | 4.4 | 4.7 | 4.7 | 11.7 |
Profitability Ratios Profitability Ratios |
| 26.5 | 31.3 | 30.2 | 31.3 | 30.2 | 25.9 |
| 7.1 | 10.3 | 7.8 | 7.3 | 7.9 | 5.5 |
| 0.3 | 1.8 | 1.1 | 1.0 | 0.7 | -1.3 |
| 7.2 | 11.6 | 8.3 | 8.5 | 7.6 | 5.5 |
| 0.9 | 6.0 | 4.0 | 4.0 | 2.5 | -3.0 |
| 0.3 | 1.9 | 1.1 | 1.1 | 0.6 | -1.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Godavari Biorefineries Limited (**GBL**), a flagship of the **Somaiya Group**, is a leading Indian integrated biorefinery and a pioneer in "Green Chemistry." The company utilizes a circular economy model to transform sugarcane and other biomass into a diversified portfolio of high-value products, including **sugar**, **ethanol**, **bio-based specialty chemicals**, and **renewable power**. Following its **October 2024 IPO**, GBL is aggressively transitioning from a traditional sugar processor into a high-margin specialty chemicals and life sciences innovator.
---
### **Integrated Manufacturing & Infrastructure Strategy**
GBL operates two strategically located manufacturing facilities in high-recovery sugarcane regions, supported by three **DSIR-registered R&D centers**.
| Facility | Location | Primary Operations | Key Capacities (as of 2024-25) |
| :--- | :--- | :--- | :--- |
| **Sameerwadi** | Karnataka | Sugar, Distillery, Co-generation | **20,000 TCD** Crushing; **570 KLPD** Ethanol; **45+ MW** Power |
| **Sakarwadi** | Maharashtra | Bio-based Specialty Chemicals | Production of **Ethyl Acetate**, **MPO**, **1,3 Butylene Glycol** |
* **Record Operational Performance:** In the **2025-26** crushing session, the Sameerwadi unit achieved its highest-ever crushing of **0.25 crore tonnes**.
* **Feedstock Diversification:** To mitigate agri-climatic and regulatory risks, GBL is commissioning a **200 KLPD grain-based distillery** (expected **Q1 FY27**). This enables a fungible, dual-feedstock model (rice/maize) to ensure year-round distillery utilization.
* **Energy Self-Sufficiency:** **84-85%** of total energy consumption is derived from renewable sources, primarily **bagasse**. The company is a net exporter of green power to the grid and operates a **1 MW** solar plant with an additional **500 KW** planned for 2026.
---
### **Business Segments & Revenue Mix**
The company’s integrated model allows it to pivot production based on market conditions and government policy (e.g., ethanol blending mandates).
| Segment | Revenue Contribution (FY25) | Key Products / Brands | Strategic Focus |
| :--- | :--- | :--- | :--- |
| **Sugar & Co-gen** | **36%** | Refined/Brown sugar, Jaggery; **Jivana** | Transitioning to retail/branded sales. |
| **Distillery** | **31%** | Fuel Ethanol, Rectified Spirits, **ENA** | Supporting India’s **20% blending target**. |
| **Bio-based Chemicals** | **29%** | Ethyl Acetate, **MPO**, **1,3 Butylene Glycol** | High-margin "Green Chemistry" for global markets. |
* **Bio-based Chemicals Leadership:** GBL is the **sole producer of bio-ethyl acetate** in India and one of only two global manufacturers of **natural 1,3 butylene glycol**. Specialty chemicals now account for **62%** of this segment's revenue.
* **Consumer Brand (Jivana):** The retail brand has expanded from **2,200** outlets in FY23 to over **7,500** outlets in 9M FY26. It achieved **15X** gross sales growth on Zepto within one year of listing.
* **Global Reach:** GBL exports to over **34 countries**, including the USA, EU, Japan, and Australia, serving blue-chip clients such as **Hershey's India**, **Coca-Cola**, **Synthomer**, and **LANXESS**.
---
### **R&D, Biotechnology, and Climate Innovation**
GBL maintains a heavy focus on original research, employing over **50 researchers** and holding **54 patent registrations** globally.
* **Sathgen Therapeutics:** This division is developing novel small molecules for **Triple-Negative Breast Cancer (TNBC)**. Phase I safety trials were successfully concluded with no dose-limiting toxicity. GBL incorporated **Sathgen Therapeutics LLC** (USA) in 2025 to facilitate global IP licensing.
* **Climate Technology:** GBL developed the **world’s first one-step process** to convert biogenic **CO2 and Hydrogen directly into Dimethyl Ether (DME)**, a clean fuel substitute for LPG.
* **Advanced Bio-Alcohols:** Secured an exclusive India license from **Catalyxx Inc.** to produce up to **30,000 MTPA** of biobutanol and higher alcohols.
* **2G Ethanol:** Developing a demonstration plant for **second-generation ethanol** using bagasse, supported by a **₹15 crore** government grant.
---
### **Financial Performance & Deleveraging**
The **October 2024 IPO** raised **₹554.75 crore**, which fundamentally restructured the balance sheet.
| Metric (Consolidated) | FY 2023-24 | FY 2024-25 |
| :--- | :--- | :--- |
| **Revenue from Operations** | **₹1,686.67 Cr** | **₹1,870.25 Cr** |
| **EBITDA Margin** | **9.0%** | **6.0%** |
| **Debt-to-Equity Ratio** | **2.55x** | **0.91x** |
| **Current Ratio** | **0.95** | **1.13** |
| **Total Debt/PBILDT** | **4.53x** | **4.93x** |
* **Debt Reduction:** GBL utilized **₹240 crore** from IPO proceeds to prepay high-cost debt, reducing annual repayment burdens to **₹36 crore** from FY26 onwards.
* **Profitability Targets:** The company is targeting an **EBITDA increase of ~3x** of FY25 levels by **FY29**, driven by the shift toward specialty chemicals.
* **Credit Ratings:** **CARE Ratings** reaffirmed **CARE BBB+; Stable** (Long-term) and **CARE A2** (Short-term) in March 2026.
---
### **Risk Factors & Contingent Liabilities**
GBL operates in a complex regulatory and agro-climatic environment that introduces significant volatility.
* **Regulatory Exposure:** Profitability is sensitive to the **Fair and Remunerative Price (FRP)** of sugarcane (increased to **₹355/quintal** for 2025-26) and government-mandated ethanol procurement prices.
* **Seasonality & Working Capital:** Operations are concentrated in **H2** (Nov–April), leading to high inventory holding periods of **155-160 days** and fund-based limit utilization of **~94%**.
* **Legal & Tax Headwinds:**
* **GST Dispute:** A demand of **₹46.85 crore** (plus penalty) regarding GST on **Extra Neutral Alcohol (ENA)** is currently stayed by the Karnataka High Court.
* **Income Tax:** Outstanding demands for **AY 2021-22** and **AY 2023-24** totaling over **₹73 crore** are under appeal.
* **Environmental:** Ongoing NGT/CPCB investigations regarding pollution allegations with a final hearing scheduled for **June 2025**.
* **Agro-Climatic Risk:** Dependence on monsoon patterns affects sugarcane recovery rates (currently **~11%**) and crushing duration.